ABUS vs FTV · P/E 5.4, rev $6.2M vs P/E 31, rev $6.23B
Arbutus Biopharma Corp (ABUS) versus Fortive Corp (FTV) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Not investment advice. Open the ABUS and FTV stock pages for the full models.
Not investment advice.